At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Randomized, Double-Blind, Double Dummy, 6-Period, Placebo-Controlled, Crossover Study to Explore and Compare the Ventilatory Response to Hypercapnia (VRH), of Belbuca, Oxycodone Hydrochloride (HCl) and Placebo in Recreational Opioid Users
In Brief
A Phase 1 clinical trial evaluating Belbuca 300 µg, Belbuca 600 µg, and 4 other interventions for Respiratory Depression. Completed, enrolled 19 participants across 1 site.
Detailed Summary
The purpose of this study is to explore and compare VRH after administration of Belbuca, Oxycodone HCl and Placebo in recreational opioid users. This is a single-center, double -blind, double-dummy , placebo-controlled randomized crossover study in up to 18 men and women self identifying as recreational users. This study will consist of a screening phase, treatment phase (which includes the Naloxone Challenge test) and follow-up visit.
Study Details
Timeline
Interventions
Belbuca 300 µg buccal film
Belbuca 600 µg buccal film
Belbuca 900 µg buccal film
Oxycodone 30 mg capsule
Oxycodone 60 mg capsule
placebo buccal film and oral placebo